While we demonstrated that MYO1G promoter hypomethylation may regulate gene expression and immune cell infiltration in melanoma patients based on multi-omics data from TCGA, it is important to acknowledge that these observations are derived from correlative bioinformatic analyses. This evidence concerns the gene MYO1G and melanoma.